All Stories

  1. Purtscher-like retinopathy as a presenting ocular manifestation of biopsy-proven giant cell arteritis: A case report
  2. Water-Free Cyclosporine 0.1% in Dry Eye Disease: Formulation Rationale, Clinical Evidence, and Unresolved Questions
  3. Dexamethasone Implant in Epiretinal Membrane Surgery: A Clinically Oriented Narrative Review of Current Evidence, Biomarkers and Patient Selection
  4. Letter to the Editor Regarding “Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials”
  5. Prevalence of and risk factors for diabetic retinopathy: The Thessaloniki Eye Study
  6. Retinal anti-VEGF treatment now, and what next? From loading doses to long-game thinking
  7. Dexamethasone Intravitreal Implant as an Adjunct to Vitrectomy with Epiretinal Membrane Peeling: A Review of the Literature
  8. The Therapeutic Approach and Mechanism of Action of Insulin Eye Drops for the Treatment of Neurotrophic Keratitis
  9. Gene Therapy Advancements in Age-Related Macular Degeneration Treatment
  10. Recent Advances in Ophthalmic Imaging: A Decade in Review
  11. Anti-VEGF Agents and the Inner Retina in nAMD: A Narrative Review of RNFL and Ganglion Cell Changes
  12. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  13. Oral therapies for diabetic retinopathy: Addressing an unmet need or a distant prospect?
  14. Management of fibrosis in neovascular age-related macular degeneration
  15. Editorial: Reviews in: ophthalmology 2024
  16. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...
  17. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  18. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
  19. In silico trials in ocular drug development: a new frontier in ophthalmology
  20. Editorial: Updates in ocular therapeutics and surgery, volume IV
  21. The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
  22. GBD 2023 Cardiovascular Disease Collaborators
  23. Clinical Outcomes of Repeated Corneal Crosslinking for Progressive Keratoconus After Failure of Primary Procedure; Safety and Efficacy at 12-Month Follow-Up
  24. Functionally deficient UBOX5 variants and primary angle-closure glaucoma
  25. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage
  26. Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  27. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  28. Repeated corneal crosslinking for progressive keratoconus: efficiency and safety
  29. Real-life visual acuity outcomes following extended depth of focus intraocular lens implantation post-phacoemulsification targeting very mild myopia
  30. Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions
  31. Efficacy of Intravitreal Dexamethasone Implant (Ozurdex®) in Naïve and Refractory Patients with Different Morphological Subtypes of Diabetic Macular Edema
  32. Retinal Biomarkers in Diabetic Retinopathy: From Early Detection to Personalized Treatment
  33. Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021
  34. The Seasonality of Retinal Detachment: Peaks, Troughs, and Global Trends
  35. Editorial: Updates in ocular therapeutics and surgery, volume III
  36. Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation
  37. Effects of Dexamethasone Intravitreal Implant on Multifocal Electroretinography in Diabetic Macular Oedema
  38. Symptomatic Vitreous Opacities: Exploring the Mismatch between Clinical Observation of Vitreous Alterations and Self-Reported Symptoms
  39. Descemet Membrane Endothelial Keratoplasty Graft Preparation Using the Liquid Bubble Technique with Subtrabecular Hydrodissection: A Retrospective Real-Life Study
  40. Emerging Applications of Intraoperative Optical Coherence Tomography in Corneal Surgery: A Narrative Review
  41. Violating independence assumption in medical statistics
  42. A model for anterior vitrectomy in real patients: is it safe, ethical and necessary?
  43. Editorial: Reviews in: ophthalmology 2023
  44. Transforming the future of ophthalmology: artificial intelligence and robotics’ breakthrough role in surgical and medical retina advances: a mini review
  45. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  46. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a syst...
  47. Burden of disease scenarios for 204 countries
  48. Neurovascular Adverse Effects of Sars-Cov-2 Vaccination
  49. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
  50. Angioid Streaks Remain a Challenge in Diagnosis, Management, and Treatment
  51. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  52. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  53. Revolutionizing Stroke Recovery: Unveiling the Promise of Stem Cell Therapy
  54. Current Challenges in the Management of Vitreoretinal Conditions
  55. Editorial: Updates in ocular therapeutics and surgery, volume II
  56. Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?
  57. Prevalence and Associations of Epiretinal Membranes in an Elderly English Population: The Bridlington Eye Assessment Project
  58. A model for anterior vitrectomy in real patients: Simulation for practical training
  59. The Role of Rho Kinase Inhibitors in Corneal Diseases
  60. The Effects of Uneventful Phacoemulsification on Subfoveal Choroidal Thickness
  61. Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies
  62. Editorial: Reviews in: ophthalmology 2022
  63. Optical coherence tomography angiography: a review of the current literature
  64. Statistical Analysis in Clinical and Experimental Medical Research: Simplified Guidance for Authors and Reviewers
  65. Sympathetic Ophthalmia after Vitreoretinal Surgery without Antecedent History of Trauma: A Systematic Review and Meta-Analysis
  66. Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies
  67. Editorial: Updates in ocular therapeutics and surgery
  68. Optical coherence tomography angiography (OCTA): A review of the current literature
  69. Real world outcomes of the new Tecnis Eyhance IOL
  70. Prevalence of Reduced Vision among UK Elderly Drivers: The Bridlington Eye Assessment Project (BEAP)—A Cross-Sectional Study
  71. Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies
  72. The Impact of the COVID-19 Pandemic and Lockdown on Macular Hole Surgery Provision and Surgical Outcomes: A Single-Centre Experience
  73. First Report of Flipping Endothelial Graft Technique Effectiveness in a Non-Fuchs Patient
  74. Advances in the Management of Aphakia
  75. Postoperative sepsis after colorectal surgery: a prospective single-center observational study and review of the literature
  76. Surgical Management of Paediatric Aphakia in the Absence of Sufficient Capsular Support
  77. The Diagnostic Value of Optical Coherence Tomography Angiography in Glaucoma
  78. Risk of surgical site infections after colorectal surgery and the most frequent pathogens isolated: a prospective single-centre observational study
  79. The Effect of Antiglaucoma Procedures (Trabeculectomy vs. Ex-PRESS Glaucoma Drainage Implant) on the Corneal Biomechanical Properties
  80. The Effect of Antiglaucoma Procedures (Trabeculectomy vs. Ex-PRESS Glaucoma Drainage Implant) on the Corneal Biomechanical Properties
  81. Clinical outcomes after intracorneal ring segment implantation for keratoconus management in corneas with mild apical haze
  82. Optical coherence tomography biomarkers for visual acuity in patients with idiopathic epiretinal membrane
  83. First report of a new corneal pathogen: Phaeoacremonium parasiticum
  84. Ab interno trabecular bypass surgery with iStent® and iStent inject® for open angle glaucoma
  85. Ocular toxoplasmosis in a patient treated with ustekinumab for psoriasis
  86. Intraocular Pressure Elevation in Keratoconus with Coexisting Pseudoexfoliation Glaucoma: How Important is the Method of Measurement?
  87. Advances in intravitreal therapy and implants: where are we now?
  88. Risk of posterior capsular rupture during phacoemulsification cataract surgery in eyes with previous intravitreal antivascular endothelial growth factor injections
  89. Stellate Nonhereditary Idiopathic Foveomacular Retinoschisis in a Female Patient: Case Report and Brief Literature Review
  90. The Risk of Posterior Capsule Rupture during Phacoemulsification Cataract Surgery in Eyes with Previous Intravitreal Anti Vascular Endothelial Growth Factor Injections.
  91. The long-term efficacy and safety of fluocinolone acetonide intravitreal implant 190 μg (ILUVIEN®) in diabetic macular oedema in a multi-ethnic inner-city population
  92. Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges
  93. Dexamethasone intravitreal implant (OZURDEX®) for macular edema secondary to noninfectious uveitis: a review of the literature
  94. Effect of Aflibercept on Cystoid Macular Edema Associated with Central Retinal Vein Occlusion. Results from a District Hospital in the United Kingdom
  95. Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
  96. Re: Hoogewoud et al.: Prognostic factors in syphilitic uveitis (Ophthalmology. 2017;124:1808-1816)
  97. Evolution of intravitreal therapy for retinal and macular disorders
  98. Effect of Conus Eccentricity on Visual Outcomes After Intracorneal Ring Segments Implantation in Keratoconus
  99. Author's Reply
  100. Collagen Cross- Linking for Paediatric Keratoconus
  101. Recurrence of keratoconus after deep anterior lamellar keratoplasty following pregnancy
  102. Modified deep sclerectomy combined with Ex-PRESS filtration device versus trabeculectomy for primary open angle glaucoma
  103. Dark Adaptation in Patients with Primary Open-Angle Glaucoma, Pseudoexfoliation Glaucoma and Childhood Glaucoma
  104. Unilateral myelinated retinal nerve fibers
  105. Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro study
  106. Trabeculectomy with or without Anterior Chamber Maintainer: A Study on Intraocular Pressure, Endothelial Cells, and Central Corneal Thickness
  107. Comparison of Dorzolamide/Timolol vs Brinzolamide/Brimonidine Fixed Combination Therapy in the Management of Primary Open-Angle Glaucoma
  108. Transepithelial Corneal Cross-linking Using an Enhanced Riboflavin Solution
  109. Helicoid Peripapillary Chorioretinal Degeneration Complicated by Choroidal Neovascularization
  110. “Association between platelet activating factor acetylhydrolase and diabetic retinopathy: Does inflammation affect the retinal status?”
  111. Ocular anterior segment changes and corneal biomechanics in pregnancy
  112. Risk Factors for Ocular Hypertension After Penetrating Keratoplasty
  113. Corneal biomechanical properties in patients with Graves' Disease
  114. Comparative Study of Refractive Errors, Strabismus, Microsaccades, and Visual Perception Between Preterm and Full-Term Children With Infantile Cerebral Palsy
  115. Ranibizumab for the treatment of degenerative ocular conditions
  116. Ischemic Optic Neuropathy after a Long Airplane Flight: Coincidence or Rare Economy Class Syndrome Manifestation?
  117. Choroidoretinal granuloma in a young female patient
  118. Nonsensory Effects of Reduced Corneal Nerve Density in Congenital Glaucoma
  119. Corneal Topographical and Biomechanical Variations Associated With Hypothyroidism
  120. Idiopathic macular epiretinal membrane surgery with simultaneous internal limiting membrane peeling. The experience of the Fribourg Eye Clinic
  121. Effect of hyperprolactinaemia on intra‐ocular pressure
  122. Intravitreal ranibizumab in choroidal neovascularisation due to multifocal choroiditis and panuveitis syndrome
  123. Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration
  124. Impact of Collagen Cross-Linking for Keratoconus on Corneal Sensitivity
  125. Pellucid marginal degeneration and keratoconus; Differential diagnosis by corneal topography
  126. Effect of Tafluprost 0.0015% on Central Corneal Thickness in Patients With Primary Open-angle Glaucoma
  127. Letter to the editor: Visual outcomes after pituitary surgery
  128. Phthiriasis palpebrarum
  129. Efficacy of autologous platelets in macular hole surgery
  130. Macular hole formation after toxoplasmic retinochoroiditis: coincidence or rare complication?
  131. Giant iris cyst in an 11-year-old child
  132. Macular hole formation after toxoplasmic retinochoroiditis